172 related articles for article (PubMed ID: 36926933)
1. Impact of Neuroeffector Adrenergic Receptor Polymorphisms on Incident Ventricular Fibrillation During Acute Myocardial Ischemia.
Chevalier P; Roy P; Bessière F; Morel E; Ankou B; Morgan G; Halder I; London B; Minobe WA; Slavov D; Delinière A; Bochaton T; Paganelli F; Lesavre N; Boiteux C; Mansourati J; Maury P; Clerici G; Winum PF; Huebler SP; Carroll IA; Bristow MR
J Am Heart Assoc; 2023 Mar; 12(6):e025368. PubMed ID: 36926933
[TBL] [Abstract][Full Text] [Related]
2. Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction.
Jabbari R; Jabbari J; Glinge C; Risgaard B; Sattler S; Winkel BG; Terkelsen CJ; Tilsted HH; Jensen LO; Hougaard M; Haunsø S; Engstrøm T; Albert CM; Tfelt-Hansen J
BMC Med Genet; 2017 Nov; 18(1):138. PubMed ID: 29162046
[TBL] [Abstract][Full Text] [Related]
3. Identification of Cx43 variants predisposing to ventricular fibrillation in the acute phase of ST-elevation myocardial infarction.
Chevalier P; Moreau A; Bessière F; Richard S; Chahine M; Millat G; Morel E; Paganelli F; Lesavre N; Placide L; Montestruc F; Ankou B; Puertas RD; Asatryan B; Delinière A;
Europace; 2023 Feb; 25(1):101-111. PubMed ID: 35942675
[TBL] [Abstract][Full Text] [Related]
4. A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction.
Jabbari R; Glinge C; Jabbari J; Risgaard B; Winkel BG; Terkelsen CJ; Tilsted HH; Jensen LO; Hougaard M; Haunsø S; Engstrøm T; Albert CM; Tfelt-Hansen J
PLoS One; 2017; 12(1):e0170193. PubMed ID: 28085969
[TBL] [Abstract][Full Text] [Related]
5. Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.
Yilmaz A; Kaya MG; Merdanoglu U; Ergun MA; Cengel A; Menevse S
J Clin Lab Anal; 2009; 23(4):237-43. PubMed ID: 19623647
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark.
Jabbari R; Engstrøm T; Glinge C; Risgaard B; Jabbari J; Winkel BG; Terkelsen CJ; Tilsted HH; Jensen LO; Hougaard M; Chiuve SE; Pedersen F; Svendsen JH; Haunsø S; Albert CM; Tfelt-Hansen J
J Am Heart Assoc; 2015 Jan; 4(1):e001399. PubMed ID: 25559012
[TBL] [Abstract][Full Text] [Related]
7. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
Magvanjav O; McDonough CW; Gong Y; McClure LA; Talbert RL; Horenstein RB; Shuldiner AR; Benavente OR; Mitchell BD; Johnson JA;
Stroke; 2017 May; 48(5):1337-1343. PubMed ID: 28351962
[TBL] [Abstract][Full Text] [Related]
10. Electrocardiographic parameters effectively predict ventricular tachycardia/fibrillation in acute phase and abnormal cardiac function in chronic phase of ST-segment elevation myocardial infarction.
Yu Z; Chen Z; Wu Y; Chen R; Li M; Chen X; Qin S; Liang Y; Su Y; Ge J
J Cardiovasc Electrophysiol; 2018 May; 29(5):756-766. PubMed ID: 29399929
[TBL] [Abstract][Full Text] [Related]
11. Potassium Disturbances and Risk of Ventricular Fibrillation Among Patients With ST-Segment-Elevation Myocardial Infarction.
Ravn Jacobsen M; Jabbari R; Glinge C; Kjær Stampe N; Butt JH; Blanche P; Lønborg J; Wendelboe Nielsen O; Køber L; Torp-Pedersen C; Pedersen F; Tfelt-Hansen J; Engstrøm T
J Am Heart Assoc; 2020 Feb; 9(4):e014160. PubMed ID: 32067598
[TBL] [Abstract][Full Text] [Related]
12. Early prediction of ventricular fibrillation using electrocardiographic characteristics in prehospital suspected ST-segment elevation myocardial infarction: a case-control study.
Tanguay A; Lebon J; Hébert D
CJEM; 2023 Sep; 25(9):728-735. PubMed ID: 37572268
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Characteristics, and Outcomes of Ventricular Fibrillation Complicating Acute Myocardial Infarction in Women Admitted Alive in the Hospital.
Weizman O; Marijon E; Narayanan K; Boveda S; Defaye P; Martins R; Deharo JC; Laurent G; Klug D; Sadoul N; Hocini M; Mansencal N; Anselme F; Da Costa A; Maury P; Ferrières J; Schiele F; Simon T; Danchin N;
J Am Heart Assoc; 2022 Sep; 11(17):e025959. PubMed ID: 36017613
[TBL] [Abstract][Full Text] [Related]
14. Life-threatening arrhythmias in anterior ST-segment elevation myocardial infarction patients treated by percutaneous coronary intervention: adverse impact of morphine.
Sauer F; Jesel L; Marchandot B; Derimay F; Bochaton T; Amaz C; Roubille F; Cayla G; Rioufol G; Garcia-Dorado D; Claeys M; Angoulvant D; Bonnefoy-Cudraz E; Guérin P; Trinh A; Matsushita K; Ohlmann P; Jossan C; Mewton N; Ovize M; Morel O
Eur Heart J Acute Cardiovasc Care; 2021 May; 10(4):427-436. PubMed ID: 33620376
[TBL] [Abstract][Full Text] [Related]
15. Differences in clinical characteristics in patients with first ST-segment elevation myocardial infarction and ventricular fibrillation according to sex.
Jabbari R; Glinge C; Risgaard B; Lynge TH; Winkel BG; Haunsø S; Albert CM; Engstrøm T; Tfelt-Hansen J
J Interv Card Electrophysiol; 2017 Oct; 50(1):133-140. PubMed ID: 28939955
[TBL] [Abstract][Full Text] [Related]
16. Hyperuricemia is associated with an increased prevalence of ventricular tachycardia and fibrillation in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention.
Hu X; Fu S; Wang S
BMC Cardiovasc Disord; 2022 Apr; 22(1):199. PubMed ID: 35473480
[TBL] [Abstract][Full Text] [Related]
17. β
Lakkiss B; Refaat MM
J Am Heart Assoc; 2023 Mar; 12(6):e029102. PubMed ID: 36927047
[No Abstract] [Full Text] [Related]
18. Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
Pacanowski MA; Zineh I; Li H; Johnson BD; Cooper-DeHoff RM; Bittner V; McNamara DM; Sharaf BL; Merz CN; Pepine CJ; Johnson JA
J Transl Med; 2008 Mar; 6():11. PubMed ID: 18331634
[TBL] [Abstract][Full Text] [Related]
19. Early Ventricular Tachycardia or Fibrillation in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention and Impact on Mortality and Stent Thrombosis (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial).
Kosmidou I; Embacher M; McAndrew T; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
Am J Cardiol; 2017 Nov; 120(10):1755-1760. PubMed ID: 28867126
[TBL] [Abstract][Full Text] [Related]
20. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
